PHS
TXT icon

PFM Health Sciences’s Textron TXT Stock Holding History

PFM Health Sciences’s Portfolio TXT Stock Details TXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,573,009
Closed -$66.1M – 95
2015
Q4 		$66.1M Buy
1,573,009
+1,215,621
+340% +$50.2M 2.01% 18
2015
Q3 		$13.5M Buy
+357,388
New +$14.8M 0.38% 53

Other funds holding TXT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PFM Health Sciences's TXT Position: Q1 2016 in Review

PFM Health Sciences sold out of Textron (TXT) in Q1 2016, closing a stake of 1,573,009 shares — an estimated $66.1M sold.

PFM Health Sciences first reported a position in TXT in Q3 2015 and held it in 2 quarters. The position peaked at $66.1M in Q4 2015. 393 funds tracked by Wall St. Rank hold TXT as of Q1 2016.

  • PFM Health Sciences reported no remaining Textron position as of Q1 2016 after selling out during the quarter.
  • PFM Health Sciences sold 1,573,009 Textron shares in Q1 2016, an estimated $66.1M.
  • PFM Health Sciences first reported a position in Textron in Q3 2015 and held it in 2 quarters.
  • PFM Health Sciences's Textron position peaked at $66.1M in Q4 2015.
  • 393 funds tracked by Wall St. Rank held Textron as of Q1 2016.

Based on PFM Health Sciences's 13F filing for Q1 2016, filed 16 May 2016.